Coloplast is a Danish multinational company that develops, manufactures, and markets medical devices and services related to ostomy care, urology and continence care, wound and skin care. Their mission is to make life easier for people with deeply personal and private medical conditions. They work closely with healthcare professionals and end-users to create solutions that are sensitive to their special needs, helping them live a more active and fulfilling life. Coloplast is committed to innovation, quality, and understanding the challenges faced by their users.
The Humlebæk headquarters serves as the central hub for Coloplast's global operations, including executive leadership, strategic planning, research and development, global marketing, and corporate support functions.
The headquarters is known for its modern Scandinavian architecture, featuring open-plan workspaces designed to foster collaboration and innovation. It incorporates sustainable design principles and often includes employee wellness facilities and green spaces.
The work culture at Coloplast's HQ is typically described as patient-centric, innovative, and collaborative. There's a strong emphasis on teamwork, ethical responsibility, and a passion for making a difference in people's lives. Employees often highlight the supportive environment and opportunities for professional growth.
The headquarters is significant as the birthplace of many of Coloplast's innovations and the command center for its worldwide activities. It symbolizes the company's Danish roots and its commitment to high-quality healthcare solutions.
Coloplast has a strong global presence, with products sold in over 140 countries. The company supports its international operations through a network of sales offices, manufacturing facilities, and distribution centers worldwide. Key functions supported globally include R&D (primarily in Denmark, US, France), manufacturing (Denmark, Hungary, US, China, France), sales and marketing across all major regions, and customer support services tailored to local market needs.
Holtedam 1
Humlebæk
Denmark
Address: 1601 West River Rd N, Minneapolis, MN 55411, USA
Key hub for market access, customer engagement, and commercial operations in North America, a significant market for Coloplast's products.
Address: Coloplast Kft., Tatabánya Ipari Park, Búzavirág út, 2800 Hungary
Critical component of Coloplast's global supply chain, ensuring efficient production and delivery of products to European and other international markets.
Address: Room 1801, West Tower, Twin Towers, B-12 Jianguomenwai Avenue, Chaoyang District, Beijing, China
Strategic office for expanding Coloplast's presence and serving the growing healthcare needs in the Asia-Pacific region, particularly China.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Coloplast' leadership includes:
Coloplast has been backed by several prominent investors over the years, including:
Coloplast restructured its Group Executive Management effective October 1, 2023, expanding the team to drive its strategic priorities. This involved new appointments to key EVP roles.
Discover the tools Coloplast uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Coloplast commonly uses a few email formats for its employees. The most prevalent formats include using the first initial followed by the last name, or a country-specific prefix followed by initials. For general inquiries, it's always best to use official contact forms or general company email addresses found on their website.
Common formats include '[country_code][first_initial][last_initial]@coloplast.com' (e.g., dkkv@coloplast.com for specific executives) or a more general '[first_initial][last]@coloplast.com'.
Format
jdoe@coloplast.com
Example
75%
Success rate
Coloplast Investor News • February 7, 2024
Coloplast reported its Q1 2023/24 financial results, highlighting 8% organic revenue growth and an EBIT margin of 29%. The company maintained its financial guidance for the full year....more
Coloplast Press Release • July 3, 2023
Coloplast announced the successful completion of its acquisition of Kerecis, an Icelandic company specializing in fish-skin based wound care products. This strategic acquisition significantly strengthens Coloplast's presence in the advanced wound care market....more
Coloplast Investor News • November 8, 2023
Coloplast announced its full-year results for 2022/23, reporting 9% organic growth and a 30% EBIT margin. The company also provided its outlook for the 2023/24 financial year and detailed its Strive25 strategy progress....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Coloplast, are just a search away.